Raija Silvennoinen

Research output

Research output per year 2011 2021 2023 2024 2024

• 22 Article
• 4 Review Article
• 1 Chapter
• 1 Editorial
• 1 More
  • 1 Letter

Research output per year

Research output per year

Search results

• 2024

  A real-world study on the impact of infection load on mortality in multiple myeloma patients in Finland

  Anttalainen, A., Havula, E., Kysenius, K., Toppila, I., Miettinen, T., Lassenius, M., Silvennoinen, R., Partanen, A. & Putkonen, M., 16 Dec 2024, In: Annals of Hematology. 13 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File

• Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021

  Kysenius, K., Anttalainen, A., Toppila, I., Miettinen, T., Lassenius, M., Lievonen, J., Partanen, A., Silvennoinen, R. & Putkonen, M., 2024, In: Annals of Hematology. 103, p. 2931–2943 13 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File

• Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group

  Partanen, A., Waage, A., Peceliunas, V., Schjesvold, F., Anttila, P., Säily, M., Uttervall, K., Putkonen, M., Carlson, K., Haukas, E., Sankelo, M., Szatkowski, D., Hansson, M., Marttila, A., Svensson, R., Axelsson, P., Lauri, B., Mikkola, M., Karlsson, C. & Abelsson, J. & 9 others, Ahlstrand, E., Sikiö, A., Klimkowska, M., Matuzeviciene, R., Fenstad, M. H., Ilveskero, S., Pelliniemi, T.-T., Nahi, H. & Silvennoinen, R., Mar 2024, In: Cancers. 16, 5, 15 p., 1024.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

• Large differencies in age-specific survival in multiple myeloma in the nordic countries

  Hemminki, K., Zitricky, F., Försti, A., Silvennoinen, R., Vangsted, A. & Hansson, M., 2024, In: Blood cancer journal. 14, 1, 4 p., 43.

  Research output: Contribution to journal › Letter › Scientific

  Open Access

  File
• 2023

  Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy

  Luoma, S., Sergeev, P., Javarappa, K. K., Öhman, T. J., Varjosalo, M., Säily, M., Anttila, P., Sankelo, M., Partanen, A., Nihtinen, A., Heckman, C. A. & Silvennoinen, R., 4 May 2023, In: Cancers. 15, 9, 15 p., 2604.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

• Impact of the number of cryopreserved CD34(+) cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation: Experience from the GOA study

  Partanen, A., Turunen, A., Silvennoinen, R., Valtola, J., Pyörälä, M., Siitonen, T., Sikiö, A., Putkonen, M., Sankelo, M., Penttilä, K., Kuittinen, T., Mäntymaa, P., Pelkonen, J., Jantunen, E. & Varmavuo, V., Feb 2023, In: Journal of Clinical Apheresis. 38, 1, p. 33-44 12 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

• Mobilization Strategies in Myeloma Patients Intended for Autologous Hematopoietic Cell Transplantation

  Jantunen, E., Partanen, A., Turunen, A., Varmavuo, V. & Silvennoinen, R., Oct 2023, In: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie. 50, 5, p. 438–447 10 p.

  Research output: Contribution to journal › Review Article › peer-review

  Open Access

  File

• Real-world evidence of multiple myeloma treated from 2013 to 2019 in the Hospital District of Helsinki and Uusimaa, Finland

  Vikkula, J., Uusi-Rauva, K., Ranki, T., Toppila, I., Aalto-Setälä, M., Pousar, K., Vassilev, L., Porkka, K., Silvennoinen, R. & Brück, O., 13 Oct 2023, In: Future Oncology. 19, 30, p. 2029-2043 16 p.

  Research output: Contribution to journal › Article › Scientific › peer-review
• 2022

  Miten turvataan myelooman yhdenvertainen hoito tulevaisuudessa?

  Silvennoinen, R., Anttila, P., Lievonen, J., Sankelo, M., Säily, M., Partanen, A. & Putkonen, M., 2022, In: Suomen lääkärilehti. 77, 18, p. 841-844 4 p.

  Research output: Contribution to journal › Review Article › peer-review

  Open Access

  File
• 2021

  Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen

  Miettinen, J., Kumari, R., Traustadottir, G. A., Huppunen, M.-E. A., Sergeev, P., Majumder, M. M., Schepsky, A., Gudjonsson, T., Lievonen, J., Bazou, D., Dowling, P., O'Gorman, P., Slipicevic, A., Anttila, P., Silvennoinen, R., Nupponen, N. N., Lehmann, F. & Heckman, C., Apr 2021, In: Cancers. 13, 7, 21 p., 1527.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File

• Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study

  Turunen, A., Silvennoinen, R., Partanen, A., Valtola, J., Siitonen, T., Putkonen, M., Sankelo, M., Pyorala, M., Kuittinen, T., Penttila, K., Sikio, A., Savolainen, E., Mantymaa, P., Pelkonen, J., Varmavuo, V. & Jantunen, E., Jun 2021, In: Transfusion. 61, 6, p. 1830-1844 15 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File

• Long-term outcome after allogeneic stem cell transplantation in multiple myeloma

  Luoma, S., Silvennoinen, R., Rauhala, A., Niittyvuopio, R., Martelin, E., Lindström, V., Heiskanen, J., Volin, L., Ruutu, T. & Nihtinen, A., Jun 2021, In: Annals of Hematology. 100, 6, p. 1553-1567 15 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File

• Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients

  Tierney, C., Bazou, D., Majumder, M. M., Anttila, P., Silvennoinen, R., Heckman, C. A., Dowling, P. & O'Gorman, P., 18 Jun 2021, In: Scientific Reports. 11, 15 p., 12866.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File

• Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study

  Janssens, R., Lang, T., Vallejo, A., Galinsky, J., Plate, A., Morgan, K., Cabezudo, E., Silvennoinen, R., Coriu, D., Badelita, S., Irimia, R., Anttonen, M., Manninen, R.-L., Schoefs, E., Vandebroek, M., Vanhellemont, A., Delforge, M., Stevens, H., Simoens, S. & Huys, I., 6 Jul 2021, In: Frontiers in Medicine. 8, 17 p., 686165.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File

• Prognostic significance of esterase gene expression in multiple myeloma

  Kumari, R., Majumder, M. M., Lievonen, J., Silvennoinen, R., Anttila, P., Nupponen, N. N., Lehmann, F. & Heckman, C. A., 12 Apr 2021, In: British Journal of Cancer. 124, 8, p. 1428-1436 9 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File

• S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma

  Liu, M., Wang, Y., Miettinen, J. J., Kumari, R., Majumder, M. M., Tierney, C., Bazou, D., Parsons, A., Suvela, M., Lievonen, J., Silvennoinen, R., Anttila, P., Dowling, P., O’Gorman, P., Tang, J. & Heckman, C. A., 16 Aug 2021, In: Frontiers in Cell and Developmental Biology. 9, 14 p., 723016.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File
• 2020

  A candid view of CANDOR

  Silvennoinen, R. & Heckman, C. A., 18 Jul 2020, In: Lancet. 396, 10245, p. 147-148 2 p.

  Research output: Contribution to journal › Editorial › Scientific

• CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkinʼs lymphoma patients: results of the prospective multicenter Goa study

  Turunen, A., Partanen, A., Valtola, J., Ropponen, A., Siitonen, T., Kuittinen, O., Kuitunen, H., Putkonen, M., Sankelo, M., Keskinen, L., Savolainen, E.-R., Pyörälä, M., Kuittinen, T., Silvennoinen, R., Penttilä, K., Sikiö, A., Vasala, K., Mäntymaa, P., Pelkonen, J. & Varmavuo, V. & 1 others, Jantunen, E., Jul 2020, In: Transfusion. 60, 7, p. 1519-1528 10 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File

• Pleriksafori kantasolujen mobilisaatiossa autologista siirtoa varten

  Jantunen, E., Valtola, J., Partanen, A., Turunen, A., Kuittinen, T., Silvennoinen, R., Pyörälä, M., Mäntymaa, P., Pelkonen, J. & Varmavuo, V., 2020, In: Duodecim. 136, 9, p. 997-1004 8 p.

  Research output: Contribution to journal › Review Article › peer-review

  Open Access

  File
• 2019

  Blood graft composition and post-transplant recovery in myeloma patients mobilized with plerixafor: a prospective multicenter study

  Valtola, J., Silvennoinen, R., Ropponen, A., Siitonen, T., Säily, M., Sankelo, M., Putkonen, M., Partanen, A., Pyorälä, M., Savolainen, E.-R., Mäntymaa, P., Pelkonen, J., Jantunen, E. & Varmavuo, V., 28 Jan 2019, In: Leukemia & lymphoma. 60, 2, p. 453-461 9 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

• Monimuotoinen myelooma

  Säily, M., Silvennoinen, R., Jantunen, E., Anttila, P., Lievonen, J. & Putkonen, M., 2019, In: Duodecim. 135, 12, p. 1171-1179 9 p.

  Research output: Contribution to journal › Review Article › peer-review

  Open Access

  File

• RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group

  Luoma, S., Anttila, P., Säily, M., Lundan, T., Heiskanen, J., Siitonen, T., Kakko, S., Putkonen, M., Ollikainen, H., Terävä, V., Sankelo, M., Partanen, A., Launonen, K., Räsänen, A., Sikiö, A., Suominen, M., Bazia, P., Kananen, K., Lievonen, J. & Selander, T. & 7 others, Pelliniemi, T.-T., Ilveskero, S., Huotari, V., Mäntymaa, P., Tienhaara, A., Jantunen, E. & Silvennoinen, R., Dec 2019, In: Annals of Hematology. 98, 12, p. 2781-2792 12 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access
• 2018

  Erytro-, trombo- ja leukosytoosi sekä plasmaperäinen hyperviskositeetti

  Sinisalo, M. & Silvennoinen, R., 2018, Akuuttihoito-opas . Mäkijärvi, M., Harjola, V.-P., Päivä, H., Valli, J. & Vaula, E. (eds.). 20. uud. p. ed. Helsinki: Kustannus Oy Duodecim, p. 509-511 3 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter › Professional

• 2017

  Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing

  Majumder, M. M., Silvennoinen, R., Anttila, P., Tamborero, D., Eldfors, S., Yadav, B., Karjalainen, R., Kuusanmaki, H., Lievonen, J., Parsons, A., Suvela, M., Jantunen, E., Porkka, K. & Heckman, C. A., 22 Aug 2017, In: Oncotarget. 8, 34, p. 56338-56350 13 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File

• Impact of lenalidomide-based induction therapy on the mobilization of CD34(+) cells, blood graft cellular composition, and post-transplant recovery in myeloma patients: a prospective multicenter study

  Partanen, A., Valtola, J., Silvennoinen, R., Ropponen, A., Siitonen, T., Putkonen, M., Sankelo, M., Pelkonen, J., Mantymaa, P., Varmavuo, V. & Jantunen, E., Oct 2017, In: Transfusion. 57, 10, p. 2366-2372 7 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

• Kalliit myeloomalääkkeet käyttöön - mutta miten?

  Silvennoinen, R. & Jantunen, E., 2017, In: Suomen lääkärilehti. 72, 10, p. 633-633 1 p.

  Research output: Contribution to journal › Article › Professional

  Open Access

  File
• 2016

  Blood graft cellular composition and posttransplant outcomes in myeloma patients mobilized with or without low-dose cyclophosphamide: a randomized comparison

  Valtola, J., Silvennoinen, R., Ropponen, A., Siitonen, T., Saily, M., Sankelo, M., Terava, V., Putkonen, M., Kuittinen, T., Pelkonen, J., Mantymaa, P., Remes, K., Varmavuo, V. & Jantunen, E., Jun 2016, In: Transfusion. 56, 6, p. 1394-1401 8 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

• Cost analysis of a randomized stem cell mobilization study in multiple myeloma

  Varmavuo, V., Silvennoinen, R., Anttila, P., Saily, M., Sankelo, M., Putkonen, M., Ahonen, J., Mahlamaki, E., Mantymaa, P., Savolainen, E.-R., Remes, K. & Jantunen, E., Oct 2016, In: Annals of Hematology. 95, 10, p. 1653-1659 7 p.

  Research output: Contribution to journal › Article › Scientific › peer-review

  Open Access

  File
• 2011

  190 MAST CELL ACTIVATION IN VIVO IMPAIRS THE MACROPHAGE REVERSE CHOLESTEROL TRANSPORT PATHWAY IN THE MOUSE

  Silvennoinen, R., Lee-Rueckert, M., Rotllan, N., Judstrom, I., Blanco-Vaca, F., Jauhiainen, M., Metso, J., Escola-Gil, J. C. & Kovanen, P. T., 1 Jun 2011, In: Atherosclerosis. Supplements. 12, 1, p. 42 1 p.

  Research output: Contribution to journal › Article › Scientific › peer-review